# the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

> **NCT04320589** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute, Egypt** · enrollment: 30 (actual)

## Conditions studied

- Pheochromocytoma

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** General anesthetic

## Key facts

- **NCT ID:** NCT04320589
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-30
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04320589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04320589, "the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04320589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*